Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
May 24, 2008
CD14 genetics in sarcoidosis patients; who's in control?
Marcel Veltkamp, Jan C Grutters, Coline H M van Moorsel, et al.
International Journal of Molecular Sciences
|
August 26, 2023
Simultaneous Assessment of mTORC1, JAK/STAT, and NLRP3 Inflammasome Activation Pathways in Patients with Sarcoidosis
Raisa Kraaijvanger, Carmen A Ambarus, Jan Damen, et al.
The Lancet. Respiratory Medicine
|
November 25, 2022
Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial
Vivienne Kahlmann, Catharina C Moor, Sanne J van Helmondt, et al.
Respiratory Medicine
|
November 21, 2024
Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosis
Ada E M Bloem, Hanneke M Dolk, Anne E Wind, et al.
Lung
|
June 21, 2023
Improved Survival of IPF patients Treated With Antifibrotic Drugs Compared With Untreated Patients
Mark G J P Platenburg, Coline H M van Moorsel, Ivo A Wiertz, et al.
BMC Pulmonary Medicine
|
October 20, 2020
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
Vivienne Kahlmann, Montse Janssen Bonás, Catharina C Moor, et al.
Chest
|
March 30, 2013
Methotrexate vs azathioprine in second-line therapy of sarcoidosis
Adriane D M Vorselaars, Wim A Wuyts, Veronique M M Vorselaars, et al.
Respiration; International Review of Thoracic Diseases
|
December 13, 2019
Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease
Wim A Wuyts, Marlies Wijsenbeek, Benjamin Bondue, et al.
The Journal of Experimental Medicine
|
April 14, 2022
Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis
Joseph Kelich, Tomas Aramburu, Joanne J van der Vis, et al.
Lung
|
November 16, 2023
Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study
Montse Janssen Bonás, Janani Sundaresan, Ruth G M Keijsers, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG
|
May 24, 2008
CD14 genetics in sarcoidosis patients; who's in control?
Marcel Veltkamp, Jan C Grutters, Coline H M van Moorsel, et al.
International Journal of Molecular Sciences
|
August 26, 2023
Simultaneous Assessment of mTORC1, JAK/STAT, and NLRP3 Inflammasome Activation Pathways in Patients with Sarcoidosis
Raisa Kraaijvanger, Carmen A Ambarus, Jan Damen, et al.
The Lancet. Respiratory Medicine
|
November 25, 2022
Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial
Vivienne Kahlmann, Catharina C Moor, Sanne J van Helmondt, et al.
Respiratory Medicine
|
November 21, 2024
Prognostic value of the 6-min walk test derived attributes in patients with idiopathic pulmonary fibrosis
Ada E M Bloem, Hanneke M Dolk, Anne E Wind, et al.
Lung
|
June 21, 2023
Improved Survival of IPF patients Treated With Antifibrotic Drugs Compared With Untreated Patients
Mark G J P Platenburg, Coline H M van Moorsel, Ivo A Wiertz, et al.
BMC Pulmonary Medicine
|
October 20, 2020
Design of a randomized controlled trial to evaluate effectiveness of methotrexate versus prednisone as first-line treatment for pulmonary sarcoidosis: the PREDMETH study
Vivienne Kahlmann, Montse Janssen Bonás, Catharina C Moor, et al.
Chest
|
March 30, 2013
Methotrexate vs azathioprine in second-line therapy of sarcoidosis
Adriane D M Vorselaars, Wim A Wuyts, Veronique M M Vorselaars, et al.
Respiration; International Review of Thoracic Diseases
|
December 13, 2019
Idiopathic Pulmonary Fibrosis: Best Practice in Monitoring and Managing a Relentless Fibrotic Disease
Wim A Wuyts, Marlies Wijsenbeek, Benjamin Bondue, et al.
The Journal of Experimental Medicine
|
April 14, 2022
Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis
Joseph Kelich, Tomas Aramburu, Joanne J van der Vis, et al.
Lung
|
November 16, 2023
Methotrexate Polyglutamate Concentrations as a Possible Predictive Marker for Effectiveness of Methotrexate Therapy in Patients with Sarcoidosis: A Pilot Study
Montse Janssen Bonás, Janani Sundaresan, Ruth G M Keijsers, et al.
Page
of 9